Cipla seeks partner for business | Chemical & Engineering News
Volume 95 Issue 23 | p. 13 | Concentrates
Issue Date: June 5, 2017

Cipla seeks partner for business

Department: Business
Keywords: biosimilars, Cipla, Merck, divestment

The Indian drug producer Cipla is hoping to find a partner or buyer for its biosimilars business. Cipla’s strength is in small-molecule chemistry, not biologic drugs, a company executive tells C&EN. The biosimilars business operates a plant and R&D center in Goa on India’s west coast. Cipla has developed biosimilars of Genentech’s cancer drugs Avastin and Herceptin but has not launched them in regulated markets. The company’s decision comes a few weeks after Merck KGaA agreed to sell its biosimilars business to Fresenius.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment